
Indo US Bio-Tech Ltd is Rated Sell
2026-05-07 10:10:27Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Indo US Bio-Tech Ltd is Rated Sell
2026-04-26 10:10:13Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Indo US Bio-Tech Ltd is Rated Sell
2026-04-15 10:10:17Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read More
Indo US Bio-Tech Ltd is Rated Sell
2026-03-24 10:10:16Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into its performance and outlook.
Read MoreBoard Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation And Appointment Of Statutory Auditor And Internal Auditor.
16-Jun-2026 | Source : BSEPursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and SEBI Master Circulars issued thereunder we wish to inform you that the Board of Directors of the Company at its meeting held on 16th June 2026 has considered and approved the following: 1. Noted the Resignation of M/s. Gautam N Associates from the office of Statutory Auditor of the Company with effect from 15th June 2026. 2. Approved the Appointment of M/s. Bhagat & Associatesa s Statutory Auditor of the Company with effect from 16th June 2026 subject to approval of the shareholders. 3. Noted the Resignation of M/s. Raj Shah & Co. as Internal Auditor of the Company with effect from 15th June 2026. 4. Approved the appointment of M/s. J. M. Raval & Co. as Internal Auditor of the Company with effect from 16th June 2026. The Board Meeting commenced at 15:00 pm and concluded at 15:30 pm. Kindly take the above information on record.
Announcement Under Regulation 30 Of SEBI LODR (Resignation Of Existing Statutory Auditor Appointment Of New Statutory Auditor Resignation Of Existing Internal Auditor And Appointment Of New Internal Auditor)
16-Jun-2026 | Source : BSEAppointment and Resignation of Statutory Auditors and Internal Auditors.
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication of Audited Financial Results for the Quarter/ Year ended on 31st March 2026. Thanks
Corporate Actions
No Upcoming Board Meetings
Indo US Bio-Tech Ltd has declared 2% dividend, ex-date: 03 Dec 24
No Splits history available
Indo US Bio-Tech Ltd has announced 1:1 bonus issue, ex-date: 29 Aug 23
No Rights history available